The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome

/ 2021, Education and epidemiology, Scientific Publications / By

M. Gerde,E. Ibarra,R. MacKenzie,C. Fernandez Suarez,C. Heer,R. Alvarez,M. Iglesias,J. Balparda,E. Beruti and F. Rubinstein. The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome. Thrombosis Research. 2021;206:10.1016/j.thromres.2021.08.004.

Go to publication